Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review Topic of the Week
AbstractSodium-glucose cotransporter-2 inhibitors (SGLT2is) have been shown to reduce adverse cardiovascular events in patients with type 2 diabetes mellitus, all-cause mortality, and heart failure…